Dirk von Lewinski

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial”.

Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial

Nature Medicine(2023)10.1038/s41591-023-02526-x

N/A

5.5DataRank · unranked

193 citations

Dalane W. Kitzman, Melanie J. Davies, Søren Rasmussen, Eric Barros, Javed Butler +23 more

Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

The Lancet(2024)10.1016/s0140-6736(24)00469-0

N/A

5.3DataRank · unranked

335 citations

Sanjiv J. Shah, Mark C. Petrie, Barry A. Borlaug, Steen Z. Abildstrøm, Melanie J. Davies +27 more

Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction

Journal of the American College of Cardiology(2023)10.1016/j.jacc.2023.09.811

N/A

2.7DataRank · unranked

82 citations

Steen Z. Abildstrøm, Barry A. Borlaug, Melanie J. Davies, Dalane W. Kitzman, Mark C. Petrie +19 more

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

The Lancet(2025)10.1016/s0140-6736(25)01665-4

N/A

1.3DataRank · unranked

71 citations

Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash, Marc P. Bonaca, Maria Borentain +94 more

Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial

Circulation Heart Failure(2023)10.1161/circheartfailure.122.010259

N/A

1.3DataRank · unranked

52 citations

Brian Claggett, Marc A. Pfeffer, Christopher B. Granger, Lars Køber, Eldrin F. Lewis +10 more

Myofilament glycation in diabetes reduces contractility by inhibiting tropomyosin movement, is rescued by cMyBPC domains

Journal of Molecular and Cellular Cardiology(2021)10.1016/j.yjmcc.2021.08.012

N/A

0.888DataRank · unranked

33 citations

Theerachat Kampaengsri, Samantha K. Barrick, Stuart G. Campbell, Dirk von Lewinski, Peter P. Rainer +4 more

HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction

Science Translational Medicine(2020)10.1126/scitranslmed.aay7205

N/A

0.713DataRank · unranked

115 citations

Deborah Eaton, Remus M. Berretta, Laura Liesinger, Matthias Schittmayer, Juergen Gindlhuber +19 more

Finerenone According to Frailty in Heart Failure

JAMA Cardiology(2025)10.1001/jamacardio.2025.1775

N/A

0.693DataRank · unranked

14 citations

Pardeep S. Jhund, Alasdair D Henderson, Brian Claggett, Chern‐En Chiang, Gerard C.M. Linssen +18 more

Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA1c levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial

The Lancet Diabetes & Endocrinology(2025)10.1016/s2213-8587(24)00304-8

N/A

0.613DataRank · unranked

20 citations

Peter van der Meer, Subodh Verma, Shachi Patel, Khaja Chinnakondepalli, Barry A Borlaug +11 more

HDAC Inhibition Regulates Cardiac Function by Increasing Myofilament Calcium Sensitivity and Decreasing Diastolic Tension

Pharmaceutics(2022)10.3390/pharmaceutics14071509

N/A

0.423DataRank · unranked

10 citations

Thomas G. Martin, Michael Kasa, Nataša Djalinac, Senka Ljubojević-Holzer, Dirk von Lewinski +12 more

Estimated glomerular filtration rate slope and risk of primary and secondary major adverse cardiovascular events and heart failure hospitalization in people with type 2 diabetes: An analysis of the EXSCEL trial

Diabetes Obesity and Metabolism(2024)10.1111/dom.15817

N/A

0.245DataRank · unranked

4 citations

Faisal Aziz, Abubaker Suliman, Kathrin Eller, Rachid Bentoumi, John B. Buse +6 more

CaMKIIδC Drives Early Adaptive Ca 2+ Change and Late Eccentric Cardiac Hypertrophy

Circulation Research(2020)10.1161/circresaha.120.316947

N/A

0DataRank · unranked

59 citations

Anthony W. Herren, Nataša Djalinac, Julia Voglhuber, Stefano Morotti, Michael Holzer +16 more

Myofilament Glycation in Diabetes Reduces Contractility by Inhibiting Tropomyosin Movement, is Rescued by cMyBPC Domains

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.09.447778

N/A

0DataRank · unranked

2 citations

Theerachat Kampaengsri, Samantha K. Barrick, Stuart G. Campbell, Dirk von Lewinski, Peter P. Rainer +4 more

Sirtuin 4 accelerates heart failure development by enhancing reactive oxygen species-mediated profibrotic transcriptional signaling

Journal of Molecular and Cellular Cardiology Plus(2025)10.1016/j.jmccpl.2025.100299

N/A

0DataRank · unranked

5 citations

Christoph Koentges, Elisabeth Khan, Katharina Pfeil, Robert Săndulescu, Sayan Bakshi +22 more

Cardiomyocyte‐Specific Deletion of Sirtuin 5 Accelerates the Development of Heart Failure Upon Dysregulating Purine Metabolism

Acta Physiologica(2025)10.1111/apha.70120

N/A

0DataRank · unranked

1 citations

Christoph Koentges, Katharina Pfeil, Julia Lueg, Sayan Bakshi, Aleksandre Tarkhnishvili +22 more